Britain’s government promises to cut through the restrictions of planning laws. If the tennis club is held back by litigation, what hope is there for data centres, pylons and gigafactories? https://t.co/J1LAdwoFNl ...

假设以2025年上半年商业银行首套房30年期平均贷款利率3.8%为例，采用等额本息还款方式，100万元 的房贷月供约为4651元。看似并不算高的月供，累计30年却需要偿还高达167.44万元，其中利息支出就 高达67.44万元——这几乎相当于额外购买了三分之二套房子的价格！对比2025年第一季度全国平均月 收入11562元，单是房贷月供就占到了收入的近40%，远超金融专家建议的健康房贷支出比例（不超过 家庭月收入的30%）。在房价高企、工资增长滞后的现实下，许多家庭实际上背负着难以承受的债务压 力，财务焦虑指数也显著高于无贷款家庭（2024年国家金融心理健康调查显示，背负大额房贷的家庭财 务焦虑指数平均高出无贷款家庭37%）。 更令人担忧的是，2024年调查数据显示，约58%的房贷提前还 款申请因各种原因被银行拒绝或延迟处理，这进一步加剧了还款的压力和不确定性。 百万财富的三十年：房贷与储蓄的博弈 在现代社会，金钱始终是人们生活中绕不开的核心议题。无论是背负巨额房贷的压力，还是拥有百万存 款的喜悦，都深刻影响着每个人的生活轨迹。让我们聚焦100万元这笔资金，深入探讨其在30年间，分 别用于房贷和储蓄两种不同场 ...

It was like a scene out of “White Lotus,” writes columnist Julie Jargon. A group of female friends tried to plan a trip in a group chat. Things went sideways. 🔗 https://t.co/y6ieqyntFE https://t.co/NtAKHCcB7l ...

One in six Texans lives or works in a flood hazard area. Soon more will. As low-lying plains become more inhabited, politicians will have to plan better https://t.co/M3McTNl14U ...

Financial Planning - As a new mom, planning for her daughter's future is a priority [1] - The author sought advice from ChatGPT before opening a savings or brokerage account [1] - The article discusses what ChatGPT advised and what it missed in financial planning for a child's future [1]

Current and prospective parents need to calculate if they can financially subsidize an adult child for the long-term, @BrokeMillennial (via @opinion) https://t.co/onxaqcGEBp ...

Britain cannot earn a living off a genteel image of strawberries and champagne for ever. Wimbledon, like many other national assets, is stuck behind the regulatory thicket of planning law https://t.co/M7kOVXCzr0 ...

[Applause] Yeah, third session. Let's go. So, even though Nema introduced myself already a bit, I also want to give you somewhat of an in uh introduction about myself because I'm probably one of the less known speakers here tonight.Um, so I'm Flo. I'm 23 years old and as you know already I'm a recent graduate here from KLU. To give you some more of a background about myself.So I'm currently working as a product owner and as already said um we are trying to digitalize truck handling. Before that, um, I for s ...

As Medicare turns 60 on July 30th and Social Security hits 90 on Aug. 14, 80% of Americans not yet enrolled worry these programs won't be there for themNew survey of over 1,000 Americans shows that 76% underestimate average healthcare costs in retirementAUSTIN, Texas, July 10, 2025 /PRNewswire/ -- eHealth, Inc. (Nasdaq: EHTH), a leading online private health insurance marketplace, and Retirable today released new original research showing most Americans are worried about the long-term health of both Medicar ...

Core Viewpoint - Jazz Pharmaceuticals has announced the appointment of Renee Gala as the new President and CEO, effective August 11, 2025, succeeding co-founder Bruce Cozadd, who will remain as Chairperson of the Board [1][3]. Company Leadership Transition - The Board of Directors conducted a thorough search for the new CEO, focusing on both internal and external candidates, ultimately selecting Renee Gala due to her exceptional leadership qualities and experience [3]. - Bruce Cozadd, who has been with the company for 22 years, expressed pride in the company's journey and confidence in Gala's ability to lead Jazz into its next growth phase [3][4]. Renee Gala's Background - Renee Gala has over 30 years of experience in finance, strategy, corporate development, and commercialization, having served as CFO and COO at Jazz Pharmaceuticals since 2020 and 2023, respectively [2][4]. - Prior to joining Jazz, Gala held leadership roles at GRAIL Inc. and Theravance Biopharma, showcasing a strong background in the life sciences sector [4][5]. Company Strategy and Vision - Gala emphasized the company's commitment to transforming patient lives through innovative medicines and highlighted the potential for growth within Jazz's market-leading portfolio and promising pipeline [3][6]. - The company aims to continue its focus on corporate development and external innovation to drive value for patients and shareholders [3][6].